Drug · DIN 02466120
CLARITHROMYCIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 28, 2021; first marketed October 20, 2017.
- Drug Identification Number (DIN)
- 02466120
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Clarithromycin J01FA09
- Class
- Human
- Record last updated
- July 25, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLARITHROMYCIN | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 2, 2021: NOC 26589Abbreviated New Drug Submission (ANDS) · Administrative: Licensing agreement between two companies
- March 22, 2021: NOC 25493Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named CLARITHROMYCIN
- DIN 02442469 · Marketed
- DIN 02442485 · Marketed
- DIN 02466139 · Marketed
- DIN 02390116 · Cancelled Pre Market
- DIN 02390191 · Cancelled Pre Market
- DIN 02408988 · Dormant
- DIN 02408996 · Dormant